LQDA
Closed
Liquidia Technologies Inc
12.
0 (0.00%)
Last Update: 01 Jul 2025 23:23:00
Yesterday: 12.46
Day's Range: 11.85 - 12.62
Send
sign up or login to leave a comment!
When Written:
6.75
Liquidia Technologies Inc is a biopharmaceutical company that focuses on the development and commercialization of novel products based on its proprietary PRINT technology platform. The company's platform enables the precise engineering of particle shape, size, and composition for the development of therapeutics and vaccines.
Liquidia's lead product candidate, LIQ861, is a dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH). The company is also developing other product candidates for the treatment of various diseases, including vaccines for respiratory syncytial virus (RSV) and bacterial infections.
Liquidia was founded in 2004 and is headquartered in Morrisville, North Carolina. The company went public in 2018 and is listed on the NASDAQ under the ticker symbol "LQDA".
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Liquidia's lead product candidate, LIQ861, is a dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH). The company is also developing other product candidates for the treatment of various diseases, including vaccines for respiratory syncytial virus (RSV) and bacterial infections.
Liquidia was founded in 2004 and is headquartered in Morrisville, North Carolina. The company went public in 2018 and is listed on the NASDAQ under the ticker symbol "LQDA".
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








